CR
Crane Company
CR has lower modeled downside risk, despite its lower overall score.
VRT
Vertiv Holdings Co
VRT has the edge over CR overall, supported by stronger valuation and stronger modeled upside.
CR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Healthy |
CR's revenue, profitability, cash flow and balance sheet are all currently healthy.
VRT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
VRT's revenue, profitability, cash flow and balance sheet are all currently strong.
CR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 27x | $209 | — |
| Cheap | 29x | $167 | -20% |
| Fair | 31x | $180 | -14% |
| Expensive | 34x | $198 | -5.7% |
| Current | 36x | $209 | — |
Historical ranges are pointers, not guarantees.
CR's PE is in its expensive range at 36x. If earnings grow as analysts expect, today's price would be 27x next year's earnings, in its cheap range.
VRT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 23x | $210 | — |
| Current | 39x | $210 | — |
| Cheap | 58x | $308 | +47% |
| Fair | 72x | $383 | +83% |
| Expensive | 88x | $472 | +125% |
Historical ranges are pointers, not guarantees.
VRT has the edge over CR in the historical PE scenario, which offers more potential upside but is not a forecast.
CR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for CR, with profitability improving.
VRT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| Moderate |
Analysts expect strong earnings and revenue growth for VRT, with profitability improving.
CR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.81 | +34% |
| Q3 2026 | $5.83 | -6.6% |
| Q2 2026 | $5.73 | -4.7% |
| Q1 2026 | $5.57 | -3.5% |
| Q4 2025 | $6.26 | +24% |
| Q3 2025 | $6.24 | +18% |
| Q2 2025 | $6.01 | +22% |
| Q1 2025 | $5.77 | +29% |
| Q4 2024 | $5.06 | +14% |
CR's earnings per share have fallen from their peak: $5.83 over the past year, against $9.53 in mid-2022.
VRT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.14 | +71% |
| Q3 2026 | $5.35 | +102% |
| Q2 2026 | $4.42 | +111% |
| Q1 2026 | $3.98 | +131% |
| Q4 2025 | $3.41 | +166% |
| Q3 2025 | $2.65 | +75% |
| Q2 2025 | $2.09 | +62% |
| Q1 2025 | $1.72 | +64% |
| Q4 2024 | $1.28 | +7.6% |
VRT has the edge over CR on earnings, with more consistent year-over-year improvement.
CR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $754.6M | +28% |
| Q2 2026 | $724.7M | +26% |
| Q1 2026 | $696.4M | +25% |
| Q4 2025 | $581M | +6.8% |
| Q3 2025 | $589.2M | -1.3% |
| Q2 2025 | $577.2M | -0.7% |
| Q1 2025 | $557.6M | -1.4% |
| Q4 2024 | $544.1M | +2.1% |
CR's revenue is recovering but still below its 2021 peak: $755M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | -1.5 points |
| Q2 2026 | 20% | +2.1 points |
| Q1 2026 | 14% | -3.8 points |
| Q4 2025 | 18% | +1.7 points |
| Q3 2025 | 20% | +2.5 points |
| Q2 2025 | 18% | +1.2 points |
| Q1 2025 | 18% | +2.3 points |
| Q4 2024 | 16% | +3.3 points |
CR's operating margin was 19% last quarter, down 1.5 points from the same quarter a year ago.
VRT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.3B | +61% |
| Q2 2026 | $3.3B | +24% |
| Q1 2026 | $2.6B | +30% |
| Q4 2025 | $2.9B | +23% |
| Q3 2025 | $2.7B | +29% |
| Q2 2025 | $2.6B | +35% |
| Q1 2025 | $2B | +24% |
| Q4 2024 | $2.3B | +26% |
VRT has the edge over CR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +3.5 points |
| Q2 2026 | 19% | +2.7 points |
| Q1 2026 | 17% | +2.3 points |
| Q4 2025 | 20% | +0.7 points |
| Q3 2025 | 19% | +1.4 points |
| Q2 2025 | 17% | -0.4 points |
| Q1 2025 | 14% | +1.9 points |
| Q4 2024 | 19% | +4.2 points |
VRT has the edge over CR on profitability, with a higher operating margin.
CR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $116.3M | -0.4% |
| Q2 2026 | $107.7M | +21% |
| Q1 2026 | -$40.2M | +$20.2M |
| Q4 2025 | $196M | +7.2% |
| Q3 2025 | $116.8M | +61% |
| Q2 2025 | $88.9M | +63% |
| Q1 2025 | -$60.4M | +$28.6M |
| Q4 2024 | $182.9M | +25% |
CR generated $380M in free cash flow over the past year, up 16% from the year before.
VRT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $654.9M | +41% |
| Q2 2026 | $926.5M | +233% |
| Q1 2026 | $654.2M | +145% |
| Q4 2025 | $885.6M | +143% |
| Q3 2025 | $463.5M | +36% |
| Q2 2025 | $277.9M | -19% |
| Q1 2025 | $266.8M | +162% |
| Q4 2024 | $364.5M | +18% |
VRT generated $3.1B in free cash flow over the past year, up 127% from the year before.
CR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +100K shares |
| 1 year | +0.3% | +200K shares |
| 3 years | +2.3% | +1.3M shares |
| 5 years | -1.2% | -700K shares |
| Available history | -1.2% | -700K shares |
CR has the edge over VRT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $27.9M |
| Q1 2022 | $175.8M |
| Q4 2021 | $96.3M |
| Q3 2021 | — |
VRT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -64.9K shares |
| 1 year | +0.4% | +1.8M shares |
| 3 years | +1.1% | +4.4M shares |
| 5 years | +10% | +36M shares |
| Available history | +63% | +152M shares |
VRT has 393M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $599.9M |
CR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.1x | Healthy |
| Q2 2026 | 1.4x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | -0.9x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.1x | Net Cash |
CR's net debt is about 1.1 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
VRT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | 0.3x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.7x | Very low |
| Q1 2025 | 0.8x | Very low |
| Q4 2024 | 1.0x | Healthy |
VRT has the edge over CR on leverage, with a lower net debt burden relative to earnings.
CR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.1 | Neutral |
| Stochastic | 47.0 | Neutral |
CR's weekly RSI is 54 (neutral) and its Stochastic is 47 (neutral).
VRT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 26.4 | Neutral |
VRT's weekly RSI is 43 (neutral) and its Stochastic is 26 (neutral).
CR PE vs Industrials Sector
| Metric | CR | Sector median | Relative |
|---|---|---|---|
| PE | 36x | 24x | 50% above |
| PE % | 91 | 59 | 32 pts above |
CR has the edge over VRT on valuation relative to its sector.
VRT PE vs Industrials Sector
| Metric | VRT | Sector median | Relative |
|---|---|---|---|
| PE | 39x | 24x | 63% above |
| PE % | 3 | 58 | 55 pts below |
VRT is trading at 39x earnings, a 63% premium to the Industrials sector's median of 24x.
CR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.1 | 3.6% above |
| 20 week MA | $208.4 | 0.5% above |
| 50 week MA | $197.0 | 6.3% above |
| 100 week MA | $184.9 | 13% above |
CR has stronger trend alignment. CR is above 4 of 4 weekly averages versus VRT above 2 of 5.
VRT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $221.8 | 5.5% below |
| 20 week MA | $254.4 | 18% below |
| 50 week MA | $253.9 | 17% below |
| 100 week MA | $189.1 | 11% above |
| 200 week MA | $123.5 | 70% above |
VRT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 70% above its 200-week average.
CR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $105.7 | $118.1 | +12% |
| 2024 | $118.1 | $153.9 | +30% |
| 2025 | $153.9 | $187.8 | +22% |
| 2026 YTD | $187.8 | $209.5 | +12% |
CR has finished every year since 2023 higher, and it's up 12% so far in 2026.
VRT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $10.9 | $18.9 | +73% |
| 2021 | $18.9 | $24.9 | +31% |
| 2022 | $24.9 | $12.8 | -48% |
| 2023 | $12.8 | $48.0 | +275% |
| 2024 | $48.0 | $115.1 | +140% |
| 2025 | $115.1 | $167.6 | +46% |
| 2026 YTD | $167.6 | $209.6 | +25% |
VRT has the edge over CR on returns for 2026, with the stronger performance.